Results 131 to 140 of about 76,618 (225)

Certolizumab Pegol Reduced Anterior Uveitis Flares Compared With Standard Non‐Biologic Treatment: Results From an Overlap Weighting Analysis in High‐Risk Patients With Axial Spondyloarthritis

International Journal of Rheumatic Diseases, Volume 29, Issue 4, April 2026.
ABSTRACT Objective Acute anterior uveitis (AAU) is the most common extra‐musculoskeletal manifestation of axial spondyloarthritis (axSpA). This study compared the effect of the tumor necrosis factor inhibitor (TNFi) certolizumab pegol (CZP) with standard non‐biologic care, on AAU flare rate in patients with axSpA and high risk of recurrent uveitis ...
Nigil Haroon, Zeynep Baskurt, Tina Chim, Robert D. Inman, Thomas Kumke, Rachel Tham, Mindy Kim, Irene van der Horst‐Bruinsma, Lianne S. Gensler   +8 more
wiley   +1 more source

Etanercept (Enbrel®) alternative storage at ambient temperature

Clinical Pharmacology: Advances and Applications, 2017
Edel Shannon,1 Joanne Daffy,2 Heather Jones,3 Andrea Paulson,4 Steven M Vicik5 1Global Chemistry, Manufacturing, and Controls Regulatory, 2Contract Operations Quality Assurance, Pfizer Ireland Pharmaceuticals, Clondalkin, Dublin, Ireland; 3Medical ...
Shannon E, Daffy J, Jones H, Paulson A, Vicik SM   +4 more
doaj  

The metabolomics of psoriatic disease. [PDF]

, 2017
Metabolomics is an emerging new "omics" field involving the systematic analysis of the metabolites in a biologic system. These metabolites provide a molecular snapshot of cellular activity and are thus important for understanding the functional changes ...
Afifi, Ladan, Chang, Hsin Wen, Jeon, Caleb, Lee, Kristina, Liao, Wilson, Trivedi, Megha, Yan, Di   +6 more
core  

Long‐term safety and efficacy of secukinumab in paediatric severe plaque psoriasis: 236‐week, Phase 3 trial results

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page 617-625, April 2026.
In this Phase III study, secukinumab demonstrated sustained efficacy and a favourable safety profile in paediatric patients with chronic severe plaque psoriasis over a treatment period of 236 weeks. Abstract Background Plaque psoriasis, a chronic inflammatory disease, affects up to 2.1% of the global paediatric population.
Andrzej Kaszuba, Philemon Papanastasiou, Dorota Krasowska, Raul De Lucas Laguna, Michael Ziv, Shoba Ravichandran, Amita Bansal, Swapnil S. Dahale, Ruvie Martin, Bertrand Paguet, Nina Magnolo, Kulli Kingo   +11 more
wiley   +1 more source

TNF/TNF-R1 pathway is involved in doxorubicin-induced acute sterile inflammation [PDF]

, 2013
Aaes, Tania Love, Bachert, Claus, Delvaeye, Tinneke, Heyndrickx, Liesbeth, Kaczmarek, Agnieszka, Krysko, Dmitri, Krysko, Olga, Leybaert, Luc, Vandenabeele, Peter   +8 more
core   +1 more source

DAPSONE AS AN ALTERNATIVE THERAPY IN CHILDREN WITH FAMILIAL MEDITERRANEAN FEVER [PDF]

Objective: Familial Mediterranan Fever is an hereditary autoinflammatory disease that presents with recurrent febrile attacks and poly serositis. Colchicine is the only known treatment in this diease.
جهانگیری, سپیده, صالح زاده, فرهاد, محمدی کلاسرلو, ایلنار   +2 more
core  

Engagement and retention with remote monitoring in psoriasis: Findings from the mySkin study

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page e274-e277, April 2026.
Weiyu Ye, Niamh Dooley, Wei Ren Tan, Bolaji Coker, Teresa Tsakok, Lucy Moorhead, Jade Pizzato, Kingsley Powell, Madeline Kroah‐Hartman, Alexandra Paolino, Treasa Jiang, Freya Jackson‐Duffy, John Y. W. Lee, Manpreet K. Sagoo, Georgia Sewell, Camille Lancelot, Helen McAteer, John Weinman, Jonathan N. Barker, Sarah Chapman, Sam Norton, Catherine H. Smith, Satveer K. Mahil   +22 more
wiley   +1 more source

A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy

ClinicoEconomics and Outcomes Research, 2009
Giorgio L Colombo1, Sergio Di Matteo2, Ketty Peris3, Maria Concetta Fargnoli3, Maria Esposito4, Annamaria Mazzotta4, Sergio Chimenti41Faculty of Pharmacy, University of Pavia, Pavia, Italy; 2S.A.V.E.
Giorgio L Colombo, Sergio Di Matteo, Ketty Peris, Maria Concetta Fargnoli, et al.   +4 more
doaj  

Effects of sialylated oligosaccharides on the N- and O-glycosylation of etanercept in recombinant CHO cells. [PDF]

Appl Microbiol Biotechnol
Kim TH, Lee HM, Ryu SH, Kim HS, Koo SJ, Kang MJ, You J, Kim YG.   +7 more
europepmc   +1 more source

Computational modeling-directed combination treatment with etanercept and mifepristone mitigates neuroinflammation in a mouse model of Gulf War Illness. [PDF]

PLoS One
Kelly KA, Felton CM, Billig BK, Yilmaz AA, O'Callaghan JP, Craddock TJA, Broderick G, Klimas N, Michalovicz LT.   +8 more
europepmc   +1 more source